Tirzepatide access
altRx vs Maximus: Which One Offers Tirzepatide? (2026)
altRx or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 8.7 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between altRx and Maximus usually comes down to one difference that neither homepage puts in its headline.
Molecule availability is the fork here: altRx covers both semaglutide and tirzepatide, while Maximus publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest 12-month cost
- altRx — $1,068 against $1,596 at Maximus, on each provider's own best published pricing.
- Most predictable bill
- altRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- altRx — Affirm, Klarna and Afterpay.
altRx vs Maximus at a glance
The rows below are the ones that differ enough between these two to be worth your attention.
| altRx | Maximus | |
|---|---|---|
| Advertised price | Semaglutide $89/mo, tirzepatide $149/mo | $132.99/mo |
| Rate after promotions | $89/mo | $133/mo |
| Pricing structure | Flat rate at every dose | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Tirzepatide | $149/mo | Not published |
| Membership fee | None | None |
| How fast you start | 100% online medical visits | Telemedicine intake, no clinic visits |
| State coverage | Not available in every state | Not published |
| Price transparency | Published upfront | Published upfront |
| Patient reviews | 14,820 | 2,896 |
| eRxDoctor score | 8.7/10 | 7.0/10 |
What altRx and Maximus actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. The totals below are the honest version, built from the rates each provider publishes.
| altRx | Maximus | |
|---|---|---|
| First month | $89 | $133 |
| Months 2 onward | $89/mo | $133/mo |
| 6-month total | $534 | $798 |
| 12-month total | $1,068 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
altRx finishes the year $528 cheaper. For some patients the support Maximus bundles closes that gap; for a patient who only needs the prescription written, it does not.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
altRx publishes both, with tirzepatide at $149/mo. Maximus publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
If you are confident semaglutide is where you will stay, this difference costs you nothing. If you are not, it is worth more than a small monthly saving.
altRx: what you are buying
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. What it is really selling here is the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
Practically: 100% online medical visits, free, discreet 2-day delivery, and a pricing model that is flat rate at every dose.
Responsive care team for ongoing clinician-guided support. The formulary covers compounded semaglutide and compounded tirzepatide.
altRx pros
- No commitment, cancel anytime
- Free and discreet 2-day delivery
- Responsive care team for ongoing clinician-guided support
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
altRx cons
- Not available in all U.S. states
- Compounded medication, not FDA-approved branded product
Against Maximus specifically, the trade you are making: the rate is a limited offer and the platform does not operate in every state.
A closer look at Maximus
$132.99 per Month In this pairing, its distinguishing feature is a low flat rate with a simple direct-pay structure and nothing bolted on.
From signup to first shipment: telemedicine intake, no clinic visits, then home delivery. Billing follows a flat rate at every dose structure.
What continues after the first shipment: prescriptions approved by licensed doctors, filled through U.S. pharmacies. Formulary: compounded semaglutide.
Maximus pros
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
- Prescriptions approved by licensed doctors
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
The cost of choosing this over altRx: the smallest patient base here, with limited published detail on tirzepatide.
altRx or Maximus: matching the program to the patient
Choose altRx if:
- you need to spread the cost — Affirm, Klarna and Afterpay
- you want tirzepatide available without changing provider later
- you want the price you sign up at to survive titration
- the monthly rate is the constraint — $89/mo against $133/mo
Choose Maximus if:
- you want the price you sign up at to survive titration
- you would get real value from a low flat rate with a simple direct-pay structure and nothing bolted on
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
- you want to start on their timeline: telemedicine intake, no clinic visits
The compromises on both sides
On price. The monthly gap is 49% in altRx's favor. Whether that is a saving or a false economy turns on one thing: the rate is a limited offer and the platform does not operate in every state.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Financing is available through altRx (Affirm, Klarna and Afterpay).
On clinical contact. The support models differ — responsive care team for ongoing clinician-guided support against prescriptions approved by licensed doctors, filled through U.S. pharmacies — and that difference is felt in week two, not week one.
On medication. altRx covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Only altRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
The medication, not the platform
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
altRx vs Maximus: common questions
Is altRx cheaper than Maximus?
Yes, on the ongoing rate. altRx runs $89/mo once promotional pricing ends, against $133/mo at Maximus — a difference of 49%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both altRx and Maximus price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
Are altRx and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. altRx operates on flat rate at every dose with pricing published upfront, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Can I switch from altRx to Maximus later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Is altRx or Maximus better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. altRx publishes responsive care team for ongoing clinician-guided support, which is the more useful thing to buy at the start.
Do altRx and Maximus prescribe the same medication?
Both dispense compounded GLP-1 preparations. altRx lists compounded semaglutide and compounded tirzepatide and Maximus lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Does altRx or Maximus offer tirzepatide?
altRx does, at $149/mo. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
On the numbers, altRx wins the year: $1,068 against $1,596. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where Maximus justifies itself is a low flat rate with a simple direct-pay structure and nothing bolted on. Where it does not is anywhere the extra spend buys features you will never open.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- altRx vs MeasuredHead to head
- altRx vs DirectmedsPublished price vs quote-only
- Mochi Health vs MaximusLocked price vs escalating price
- Elevate Health vs MaximusTirzepatide access
- JoinFridays vs GalaTirzepatide access
- MedVi vs Start WillowTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by altRx or Maximus, and does not sell treatment. Read our ranking methodology.